您的位置: 首页 > 2023年1月 第54卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

低氧调控p53RFP基因启动子活性的初步研究

Preliminary study of regulative function of hypoxia to the p53RFP gene promoter

来源期刊: 广州医药 | 25-29 发布时间:2023-02-07 收稿时间:2025/11/13 18:40:03 阅读量:11
作者:
关键词:
低氧p53RFP启动子低氧反应元件
hypoxiap53RFPpromoterhypoxia responsive element
DOI:
10.3969/j.issn.1000-8535.2023.01.004
收稿时间:
2022-03-08 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 观察低氧对p53RFP基因表达及启动子活性的影响,探索低氧反应元件(HRE)是否参与了低氧对p53RFP基因启动子活性的调控。方法 将HEK293细胞置于低氧条件下培养,实时定量PCR及Western blot 检测p53RFP mRNA及蛋白表达水平;通过定点突变技术构建HRE突变型p53RFP启动子双荧光素酶报告基因载体并转染HEK293细胞,分别置于常氧和低氧条件下培养,双荧光素酶报告基因检测系统检测启动子活性。结果 低氧处理不同时间点p53RFP mRNA 表达水平均显著增加,差异有统计学意义(F=96.493,P<0.001);低氧组p53RFP 及HIF-1α蛋白表达量均呈时间依赖性递增。成功构建了HRE 突变型p53RFP 启动子双荧光素酶报告基因载体,双荧光素酶报告基因检测显示,与常氧组相比,低氧条件下野生型p53RFP基因启动子活性增加(t=-19.504,P<0.001),HRE单突变或双突变后启动子活性均较野生型降低(F=160.891,P<0.001)结论 低氧可诱导p53RFP基因表达上调;成功构建了HRE 突变型p53RFP 双荧光素酶报告基因载体,HRE 位点可能在低氧调控p53RFP基因启动子活性中发挥关键作用。
Objective To investigate the effect of hypoxia on p53RFP gene expression and p53RFP promoter activity, and explore whether hypoxia responsive element (HRE) is involved in the regulation of p53RFP gene promoter activity by hypoxia. Methods HEK293 cells were cultured under normoxia and hypoxia conditions, p53RFP expressions at mRNA and protein levels were detected by real-time PCR and Western blot respectively. The HRE mutant p53RFP promoter dual luciferase reporter gene vector was constructed by site-directed mutagenesis technology and transfected into HEK293 cells under normoxia and hypoxia conditions. The promoter activities were detected by dual luciferase reporter system. Results Compared with the normoxia group, the expression of p53RFP mRNA in the hypoxia group increased significantly at different time points, and the difference was statistically significant(F=96.493,P<0.001); the expression of p53RFP and HIF-1α protein in the hypoxia group increased in a time-dependent manner. The luciferase reporter vectors containing p53RFP with mutant HRE were successfully constructed. The dual luciferase reporter gene assay showed that the activity of the wild-type p53RFP gene promoter was significantly increased under hypoxic conditions compared to normoxic condition(t=-19.504,P<0.001),and the promoter activity of p53RFP with HRE single mutation or double mutation were both significantly lower than that of wild type under hypoxic condition (F=160.891,P<0.001). Conclusions p53RFP gene expression was induced by hypoxia; the p53RFP promoter with mutant HRE dual luciferase reporter gene vectors were successfully constructed, and the HRE locus may play a key role in the hypoxia regulation of p53RFP gene promoter activity.
1、 裴静娴,王月刚,张艺军,等.p53RFP基因启动子荧光素酶报告基因载体的构建及鉴定[J]. 广东医学, 2017, 2(38): 170-172. 裴静娴,王月刚,张艺军,等.p53RFP基因启动子荧光素酶报告基因载体的构建及鉴定[J]. 广东医学, 2017, 2(38): 170-172.
2、 CONFORTI F, YANG A L, PIRO M C, et al. PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63[J]. Oncogene, 2013, 32(40): 4758-4765. CONFORTI F, YANG A L, PIRO M C, et al. PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63[J]. Oncogene, 2013, 32(40): 4758-4765.
3、 NG C C, ARAKAWA H, FUKUDA S, et al. p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1[J]. Oncogene, 2003, 22(28): 4449-4458. NG C C, ARAKAWA H, FUKUDA S, et al. p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1[J]. Oncogene, 2003, 22(28): 4449-4458.
4、 LEI L, MASON S, LIU D, et al. Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein[J]. Mol Cell Biol, 2008, 28(11): 3790-3803. LEI L, MASON S, LIU D, et al. Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein[J]. Mol Cell Biol, 2008, 28(11): 3790-3803.
5、 KUMAR S, WANG G, LIU W, et al. Hypoxia-induced mitogenic factor promotes cardiac hypertrophy via calcium-dependent and hypoxia-inducible factor-1α mechanisms[J]. Hypertension, 2018, 72(2): 331-342. KUMAR S, WANG G, LIU W, et al. Hypoxia-induced mitogenic factor promotes cardiac hypertrophy via calcium-dependent and hypoxia-inducible factor-1α mechanisms[J]. Hypertension, 2018, 72(2): 331-342.
6、 MOSLEHI J, MINAMISHIMA Y A, SHI J R, et al. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy[J]. Circulation, 2010, 122(10): 1004-1016. MOSLEHI J, MINAMISHIMA Y A, SHI J R, et al. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy[J]. Circulation, 2010, 122(10): 1004-1016.
7、 H?LSCHER M, SCH?FER K, KRULL S, et al. Unfavourable consequences of chronic cardiac HIF-1α stabilization[J]. Cardiovasc Res, 2012, 94(1): 77-86. H?LSCHER M, SCH?FER K, KRULL S, et al. Unfavourable consequences of chronic cardiac HIF-1α stabilization[J]. Cardiovasc Res, 2012, 94(1): 77-86.
8、 NECKá? J, HSU A, HYE KHAN M A, et al. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3[J]. Am J Physiol Heart Circ Physiol, 2018, 315(5): H1148-H1158. NECKá? J, HSU A, HYE KHAN M A, et al. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3[J]. Am J Physiol Heart Circ Physiol, 2018, 315(5): H1148-H1158.
9、 LI M, CUI Y, HE W, et al. Effects of triple-mutated hypoxia-inducible factor-1α on angiogenesis and cardiac function improvement in rats with myocardial infarction[J]. Cell Physiol Biochem, 2018, 50(6): 2329-2340. LI M, CUI Y, HE W, et al. Effects of triple-mutated hypoxia-inducible factor-1α on angiogenesis and cardiac function improvement in rats with myocardial infarction[J]. Cell Physiol Biochem, 2018, 50(6): 2329-2340.
10、 DARBY I A,HEWITSON T D.Hypoxia in tissue repair and fibrosis[J]. Cell Tissue Res, 2016, 365(3): 553-562. DARBY I A,HEWITSON T D.Hypoxia in tissue repair and fibrosis[J]. Cell Tissue Res, 2016, 365(3): 553-562.
11、 BENARD G, NEUTZNER A, PENG G, et al. IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation[J]. EMBO J, 2010, 29(8): 1458-1471. BENARD G, NEUTZNER A, PENG G, et al. IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation[J]. EMBO J, 2010, 29(8): 1458-1471.
12、 YU H L,CHEN B,REN Q.Baicalin relieves hypoxia-aroused H9c2 cell apoptosis by activating Nrf2/HO-1-mediated HIF1α/BNIP3 pathway[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 3657-3663. YU H L,CHEN B,REN Q.Baicalin relieves hypoxia-aroused H9c2 cell apoptosis by activating Nrf2/HO-1-mediated HIF1α/BNIP3 pathway[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 3657-3663.
13、 SOUSA FIALHO M D L, ABD JAMIL A H, STANNARD G A, et al. Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(4): 831-843. SOUSA FIALHO M D L, ABD JAMIL A H, STANNARD G A, et al. Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(4): 831-843.
14、 HU J, STIEHL D P, SETZER C, et al. Interaction of HIF and USF signaling pathways in human genes flanked by hypoxia-response elements and E-box palindromes[J]. Mol Cancer Res, 2011, 9(11): 1520-1536. HU J, STIEHL D P, SETZER C, et al. Interaction of HIF and USF signaling pathways in human genes flanked by hypoxia-response elements and E-box palindromes[J]. Mol Cancer Res, 2011, 9(11): 1520-1536.
15、 SEMENZA G L.Hypoxia-inducible factor 1 and cardiovascular disease[J]. Annu Rev Physiol, 2014(76): 39-56. SEMENZA G L.Hypoxia-inducible factor 1 and cardiovascular disease[J]. Annu Rev Physiol, 2014(76): 39-56.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录